MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2025 International Congress

    Reduced plasma levels of small HDL subfractions in advanced Parkinson’s disease

    CM. Chen, KH. Chang, ML. Cheng (Taoyuan, Taiwan)

    Objective: The present study investigated alterations of circulatory lipoprotein profiles, including cholesterol, triglycerides (TGs), phospholipids (PLs) and apolipoproteins (Apo) in lipoprotein subfractions, in Parkinson's disease…
  • 2025 International Congress

    Long-term analysis of subthalamic local field potentials (LFP) in Parkinson’s disease: Insights into circadian rhythms, medication, and personalized treatment effects

    V. Livneh, R. Naivelt, M. Zutta, Z. Katzir, R. Monteoriano, I. Strauss, K. Avirame, A. Socher, G. Morris, I. Maidan (Tel Aviv, Israel)

    Objective: investigate electrophysiological patterns related to circadian rhythms, medication intake & long-term DBS effects. Background: Deep brain stimulation (DBS) offers substantial and long-lasting motor improvements…
  • 2025 International Congress

    Real world application of alpha-synuclein skin biopsy in the diagnosis of synucleinopathies at a tertiary care center

    C. Yu, C. Cooper (Nashville, USA)

    Objective: The goal of this study is to review the real-world application of alpha-synuclein skin biopsy at a tertiary care center. Background: Synucleniopathies including Parkinson’s…
  • 2025 International Congress

    The East London Parkinson Disease Project: Higher Immune Activation found in Patients with Parkinson’s Disease Dementia from a Diverse Population

    A. Zirra, KC. Dey, E. Camboe, E. Bhadra, B. Huxford, R. Laban, N. Donkor, F. Nice, S. Valle Thomas, A. Gaspariunas, L. Mitchell, DA. Gallagher, C. Budu, C. Simonet, T. Boyle, AJ. Lees, D. Yadin, J. Dias, O. Cavlan, CR. Marshall, MT. Perinan, AJ. Noyce (London, United Kingdom)

    Objective: The scope of this work was to characterise the B-cell receptor repertoire of patients with Parkinson’s disease with dementia (PDD), cognitively resilient (PDR) and…
  • 2025 International Congress

    Prodromal Lewy body dementia features in isolated REM sleep behavior disorder with neuronal synuclein disease

    D. Weintraub (Philadelphia, USA)

    Objective: To assess for cognitive impairment and features of prodromal Lewy body dementia (LBD) in persons with isolated REM sleep behavior disorder (iRBD) and neuronal…
  • 2025 International Congress

    Evaluation Of Visual Perception Using Noise Pareidolia Test in Bangladeshi Patients with Parkinson’s disease.

    T. Zannat, E. Camboe, K. Dey, A. Zirra, A. Haque, D. Mair, S. Waters, C. Marshall, N. Mukadam, R. Weil, A. Noyce, A. Habib (Dhaka, Bangladesh)

    Objective: To evaluate the prevalence of visual misperception in patients with PD (PwP) in comparison with healthy control (HC) and its association with visual hallucinations.…
  • 2025 International Congress

    The role of interoception in motor imagery in Parkinson’s disease

    J. Bek, M. Lavasidis, N. Brady, T. Welsh (Dublin, Ireland)

    Objective: The present study explored the relationship between interoceptive awareness and motor imagery in individuals with PD. Background: Motor imagery is the imagination of movement,…
  • 2025 International Congress

    The Role of Depression and Anxiety in the Progression of Parkinson’s Disease

    N. Dahodwala, C. Hurley, T. Kapogiannis, H. Cho, C. Caspell-Garcia, D. Weintraub, R. Dobkin (Philadelphia, USA)

    Objective: To determine the association of depression and anxiety, and their treatment, with patient-reported outcomes (PROs) in a large, online, observational cohort of people with…
  • 2025 International Congress

    Approach into the genetics of cognitive performance in Mexican Parkinson’s Disease patients.

    A. Lázaro Figueroa, P. Reyes-Pérez, A. Morales, E. Morelos-Figaredo, C. Guerra-Galicia, I. Estrada-Bellmann, N. Gandarilla-Martínez, K. Salinas-Barboza, D. Oropeza, J. Esquivias, I. Hernández-Ruiz, G. de Anda, E. Waldo, T. Leal, M. Inca-Martinez, I. Mata, S. Alcauter, M. Rentería, A. Medina-Rivera, A. Ruiz-Contreras (CDMX, Mexico)

    Objective: To compare the allele frequencies of genetic variants associated with cognitive impairment between Parkinson's Disease (PD) patients and controls and to examine their interaction…
  • 2025 International Congress

    Demographic Features, QTc Interval and Psychosis in Military Veterans with Parkinson’s disease (PD)

    A. Sarwar, P. Bigner (Houston, USA)

    Objective: To compare certain key demographic features and QTc intervals in groups of PD military Veterans with and without psychosis. Background: Psychosis is a disabling…
  • « Previous Page
  • 1
  • …
  • 15
  • 16
  • 17
  • 18
  • 19
  • …
  • 181
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley